Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Olodanrigan is a novel orally available and highly selective antagonist of angiotensin II type 2 receptor (AT2R).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | Olodanrigan is a novel orally available and highly selective antagonist of angiotensin II type 2 receptor (AT2R). |
Synonyms | PD-126055, EMA401, EMA 401, EMA401 sodium, EMA-401, PD 126055 |
Molecular Weight | 530.576 |
Formula | C32H29NNaO5 |
CAS No. | 1316755-17-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Olodanrigan sodium 1316755-17-5 PD-126055 EMA401 EMA 401 PD126055 EMA401 sodium EMA-401 PD 126055 inhibitor inhibit